Bluebird Bio Inc (BLUE) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BLUE Annual Income Statement →
This income statement overview for Bluebird Bio Inc spans from Mar 31 2024 to Mar 31 2025, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
Q1 2025
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax38.71
Total Revenue38.71
Costs & Expenses
Cost of Goods and Services Sold12.24
Gross Profit26.48
Selling, Administration, Marketing30.26
Depreciation & Amortization15.54
Research and Development Expense17.72
Restructuring Charges3.10
Other Operating Expense / -Income0.00
Total operating costs including COS63.32
Operating income / -loss-24.61
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Investment Income, Interest0.61
Foreign Currency Transaction Gain (Loss), before Tax-2.31
Other loss / -income-24.41
Total costs & expenses38.91
Income & Taxes
Income / -loss before income taxes-0.20
Income taxes expenses / -benefit-0.10
Income after income taxes-0.10
Net income / -loss of other equity0.00
Income / -loss from continuing operations-0.10
Other-28.97
Net income / -loss-0.10
Income / -loss to shareholder-29.07
EBIT-0.20
EBITD15.34
EBITDA15.34
Earnings Per Share
Basic EPS (excl. extra items)-2.98
Basic Net EPS-2.98
Basic shares outstanding (Mill. of Units)9.75
Diluted Net EPS-2.98
Diluted average shares (Mill. of Units)9.75
4 historic quarters locked

Sign in to unlock the full Bluebird Bio Inc income statement history.

About Bluebird Bio Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.